Abstract: A method for treating or preventing the symptoms associated with hang over in an individual suffering from or being at risk for such conditions. The method includes the steps of: i) providing the composition of the invention containing AP, and ii) contacting AP with the mediator a) within the individual, or b) separate from the individual.

Abstract: A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X1(—R?—)(—R?)mHn where: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R?— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R?— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.

Abstract: A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic centre complying with the formula X1(—R?—)(—R?)mHn where: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) -R?- is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R?- is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.

Abstract: A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X1(—R?—)(—R?)mHn where: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R?— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R?— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.

Abstract: A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic centre complying with the formula X1(—R?—)(—R?)mHnwhere: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R?— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R?— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.

Abstract: A method for purifying a desired substance by separating from each other a substance (I) from a substance (II), one of which is the desired substance, both of which have affinity for the same ligand structure, and wherein substance (I) is smaller than substance (II). The method comprising the steps of: (i) providing substances I and II in a liquid; (ii) contacting the liquid with an adsorbent which selectively adsorbs substance I; (iii) recovering the desired substance; The adsorbent has (a) an interior part which carries a ligand structure that is capable of binding to substances I and II, and is accessible to substance I, and (b) an outer surface layer that does not adsorb substance II, and is more easily penetrated by substance I than by substance II.

Abstract: A matrix is disclosed including a core showing a system of micropores and a surface in which the micropore system has openings. The characterizing feature is that the surface is coated with a polymer (I) having such a large molecular weight that it cannot penetrate into the micropores.

Abstract: Process for, in layers of a porous matrix, exhibiting the groups A, introducing a functionality using a reagent I, introducing the functionality by a reaction with the groups A. The characterizing feature is that the matrix is contacted with a functional deficiency of reagent I and that conditions and reagent I are chosen so that the reaction between reagent I and the groups A is more rapid than diffusion of reagent I in the matrix.

Abstract: Process for separating off a peptide or a nucleic acid by an anion exchanger (I) characterized in that a) the anion exchanger (I) exhibits ligands, which (i) contain a primary, secondary or tertiary amino group and (ii) are covalently bound to an organic polymer (matrix), b) there on a carbon atom at a distance of 2 or 3 atoms away from an amino nitrogen in the ligands is a hydroxyl group or a primary, secondary or tertiary amino group, and c) the maximum elution ionic strength in the pH range 2-14 for at least one of the proteins transferrin, ovalbumin 1, ovalbumin 2, .beta.-lactoglobulin 1 and .beta.-lactoglobulin 2 on the anion exchanger is higher than the elution ionic strength required for a quaternary comparative ion exchanger.

Abstract: A liquid chromatographic system comprises at least two modules, at least one fluid flow line, and at least two connector devices provided along the flow line and respectively connecting the modules to the flow line. One of the two modules comprises a separation module and the other of the two modules comprises an ancillary module having a non-separation function. Each of the two modules includes at least one end connector fit into the respective connector device, and each end connector is adapted to interchangeably fit into either connector device.

Abstract: Special subscriber services are implemented by providing operator functionality and service logic within a transit exchange to equip it as a serving node. A subscriber connected to an end office coupled to the transmit exchange invokes the special services functionality by signalling such as by means of a long switch hook flash. Once invoked particular special services may be selected by DTMF or voice prompt signalling.

Abstract: The present invention relates to a method for grinding grooves in the peripheral surface of rollers roller guides for rolling mills. The roller (2) of a roller guide is caused to rotate while retained on its own bearing (8,9,10) as the peripheral groove is ground.The invention also relates to an apparatus for carrying out the method, and to a roller guide structure with which the method can be applied.

Abstract: The present invention relates to an agent for intravascular administration for diagnostic and/or physiologic investigations, which agent consists of or contains a suspension of minute radioactive particles in a physiologically acceptable liquid.Radioactively labelled microspheres, in suspension in a physiologically acceptable liquid, have lately been increasingly used in circulation studies, studies of the shunting phenomena, microcirculation studies, nutrition studies and as a means for carrying out scintography on man and animals.

Abstract: A dextran derivative gel for use in electrophoretic separation processes is disclosed, which gel comprises a polymerizate obtained by the free-radical homopolymerization of a dextran derivative containing vinylic groups of the formula ##STR1## wherein A is --CH.sub.2 -- or --O-- and R is a hydrogen atom, a methyl group, a trifluoromethyl group, a fluorine, chlorine or bromine atom or a cyano group, or free-radical copolymerization of such a vinylic derivative of dextran with a low-molecular weight monovinyl compound.

Abstract: A dextran derivative gel in particle form for use in the separation of substances according to their molecular size and/or electrical charge by means of gel-chromatographic and/or ion exchange techniques is disclosed which gel comprises a copolymerizate obtained by the free-radical copolymerization of a dextran derivative containing vinyl and/or substituted vinyl groups with (a) a divinyl compound of the formula ##STR1## wherein R' and R" are equal or different and each represent hydrogen or methyl and X is ##STR2## --SO.sub.2 -- or the group ##STR3## wherein n is an integer from 1 to 6, inclusive, and optionally (b) a low-molecular weight monovinyl compound.